ArticleJournal of molecular and cellular cardiology2018

A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion.

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.